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1. Introduction 
Implantation of pacemakers and implantable cardioverter defibrillators (ICDs) are common 
procedures associated with very low complication rates(1-3).  Device therapy is frequently 
used in the management of adult congenital heart disease (ACHD) patients given the high 
prevalence of arrhythmic complications encountered in this population.  The ACHD 
population continues to grow at a rapid pace.  It is estimated that that there are currently 
more surviving adults with severe congenital heart disease (CHD) than children(4). The 
prevalence of arrhythmias and conduction disorders in adults with surgically treated CHD 
as well as those with specific congenital defects associated with conduction system 
abnormalities has led to an increasing need for implantable devices (both pacemakers and 
ICDs) in these patients (5).   Unfortunately, as the indications for device implantation in 
patients with CHD have increased, so have the rate of device related infections and other 
complications leading to a growth in referrals for lead extraction in this expanding patient 
population(6-8).  A thorough understanding of the role that lead extraction plays in this 
growing subgroup of patients is therefore critical for any implanting and extracting 
practitioner.   
2. Specific challenges in the adult CHD population 
At times patients with complex CHD in need of a permanent implantable device 
(pacemaker or ICD) require epicardial lead placement. This is due to complex anatomy or 
vascular limitations that prevent access to the venous circulation or due to the presence of 
intracardiac shunts that may increase the risk of embolic events with intracardiac leads.  
However, successful transvenous lead placement is often possible in patients with CHD, 
and these procedures are done with increasing frequency in the cardiac catheterization 
laboratory(9; 10). Transvenous lead systems are preferable to epicardial leads due to their 
generally lower capture thresholds and their greater durability and longevity(11). 
Procedural risk and peri-procedural morbidity is also significantly reduced with a 
transvenous approach. Yet, many patients with CHD are young and anatomic 
considerations often place additional stress on leads requiring multiple device pulse 
generator or lead replacements over time(12). Both lower age at implantation and a 
diagnosis of CHD have been associated with increased risks of lead failure over time(13). 
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3. Lead extraction indications 
In adults with CHD, as well as in the general population of patients with implantable 
devices, the main indications for lead extraction include lead fracture, venous stenosis 
with associated superior vena cava (SVC) syndrome, infection and patient discomfort 
related to implanted materials.  Lead malfunction rates in the published literature - ICD 
leads in particular - range from 16 to 20% at 10 years(14; 15). Although this rate may not 
hold true for all modern leads, it is of significance in patients with CHD since many 
receive implants at an early age and have a cumulative risk of developing device-related 
complications.  
Over the past decade, due to expanded indications for ICDs  and a resultant dramatic 
increase in the number of devices implanted, the incidence of device infections has been 
rising(16; 17).  Infection of any of the components of the device system can lead to sepsis and 
death.  Prompt extraction of the entire device system coupled with intravenous antibiotics is 
a viable and effective treatment option to prevent these complications.   
4. General experience 
For the reasons stated above, transvenous leads are now favored over epicardial leads in 
the pediatric and young adult CHD population.  Published data on lead extraction in 
CHD patients is steadily growing but currently consists of single-center experiences with 
patient numbers far smaller than typical adult studies.(6; 18; 19)  Due to the extreme 
heterogeneity of the ACHD population,  interventions such as device extraction are often 
generalized to the entire CHD population, as the number of each individual defect type is 
often too small for meaningful comparison and reporting.  We have summarized, in table 
format, the three largest published reports on lead extraction in ACHD patients published 
to date (Table 1)(10; 19; 20). 
 
 
 
Number 
of 
patients 
Number 
of leads
Number of 
leads 
Removed 
Technique
Mean duration 
of lead 
implantation 
Indication 
Minor 
complication
Major 
complications 
Deaths 
Cecchin et al. 144 203 162 (80%) 
Laser and 
Torsion 
device. 
7.6 +-4.3 years 
Infection 
(8%);Lead failure 
(65%); Device 
upgrade (12.5%)
2.80% 2.80% None 
Khairy  et al. 16 23 21(91%) Laser 9.0 ± 5.2 years 
Infection 44%; 
Lead failure 25%; 
Device upgrade 
25%; pain 6% 
N/A 1 (6.3%) None 
Cooper et al. 14 21 20 (95%) Laser 
42.0 ± 18.9 
months 
Lead failure 
(93%) 
3 required 
transfusions 
None None 
Table 1.   
5. Planning the procedure 
The ACHD population presents several unique challenges to physicians planning a device 
extraction.  Before bringing these patients to the electrophysiology (EP) lab, the operator 
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needs to become extremely familiar with the patient, their anatomy, the device and leads.  A 
thorough understanding of the patient’s anatomy and device history is paramount to all 
other aspects of the procedure.  Understanding the anatomy in an adult with CHD includes 
knowing the original defect, previous surgeries and interventions performed on the patient, 
residual defects, chamber sizes, and vascular connections.   
In addition to the standard history, physical exam and chest x-ray (posterior-anterior and 
lateral) to assess the number and relative locations of the lead(s), a detailed review of 
previous surgical reports, echocardiography reports, advanced imaging studies, and clinical 
progress notes should be done in preparation for lead extraction in CHD patients.  
Echocardiography remains a standard component in the anatomical evaluation of CHD 
patients and transthoracic and transesophageal modalities should be used to assess for 
residual intracardiac shunts, valve function, chamber sizes, and basic lead courses and 
locations.  We routinely perform trans-esophageal echocardiograms (TEEs) prior to or 
during our device extractions.  This is particularly important in ACHD patients for several 
reasons.  Pre-procedural TEEs can confirm the diagnosis of device infection and define large 
vegetations on the leads that may contra-indicate percutaneous extraction, particularly in 
patients with intra-cardiac shunts.  Given, the risk of cerebral emboli in such patients, these 
devices are often best removed through open surgical extraction.  Cardiac computed 
tomography (CT) is quickly becoming an important tool in the care of ACHD patients by 
providing excellent images for anatomic and functional features of CHD.  Additionally, 
venous anatomy and patency can also be assessed with cardiac CT.  Finally, angiography 
can be performed at the time of the device procedure to further assess for venous patency, 
baffle obstruction or baffle leaks. 
Not only will CHD patients with devices have a broad variety of defects but their device 
and lead implant history may be equally complicated.  Some CHD patients carry a long 
history of device-related procedures dating back to early childhood years with epicardial 
systems, subcutaneous leads and arrays, pericardial leads, and transvenous implants 
together with their associated generator changes.  For others who have undergone 
transvenous implantation, it is possible to encounter patients with multiple leads and 
venous obstruction.  The operator also needs to be familiar with the lead itself including its 
fixation mechanism and type of insulation material. The manufacturer and their 
representatives can be valuable assets in obtaining this information.  Interrogation of the 
device prior to the procedure will also reveal whether the patient is dependent on its pacing 
functions  in order to determine if a temporary pacemaker will need to be placed  during the 
procedure.  At times, careful device interrogation may show apparent recovery of intrinsic 
atrio-ventricular conduction and that the patient has not been device dependent.  Such 
patients may not require immediate re-implantation and can be closely monitored to assess 
their current pacing requirements.  Any decision to delay or forego device re-implantation 
must be weighed against the possibility that conduction disease can progress over time in 
patients with CHD and that transient or permanent conduction block can recur over time.  
At the time of the procedure, interrogation of all the leads must be done. This is particularly 
important if a lead is to be re-used.  
In ACHD patients with infected device systems, a pre-procedural consultation with an 
infectious disease specialist may be warranted to provide recommendations for proper 
intravenous antibiotic therapy and timing of device re-implantation if patients are device 
dependent.  
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The decision to perform complex lead extractions or to abandon leads is another important 
consideration in CHD device procedures.  Venous access and patency remain great concerns 
in  ACHD patients with devices and this may lead the electrophysiologist to undertake 
complex extractions on multiple leads in an effort to preserve the vascular space and 
previously implanted lead courses, knowing that these patients will likely return several 
additional times in the future for similar procedures. Laser and RF extraction sheaths should 
be present and easily available during CHD lead extractions. 
Additionally, ACHD patients are at increased risk for extraction related complications.  
Surgical support should always be coordinated before CHD lead extractions and 
measures should be in place in the event that emergent surgical intervention is required.  
Interventional cardiology involvement should also be in place in the event of certain 
complications and to provide expertise in the event that leaks or stenoses require balloon 
dilation, stenting or percutaneous device closure.  Patch and baffle leaks or tears can occur 
during extraction resulting in the acute mixing of blood pools to varying extents 
depending on the size of the tear.  Certain leaks may be amenable to percutaneous device 
closure while others may require surgical intervention.  Patients should be counseled on 
these possibilities and the potential involvement of surgeons or interventional cardiologists 
to address them. Combined procedures involving both the electrophysiologist and 
interventional cardiologist can be arranged to facilitate transvenous device procedures 
that otherwise would have been contraindicated given anatomic limitations in CHD 
patients(21). 
6. Specific anatomic lesions 
6.1 Transposition of the Great Arteries 
Transposition of the great arteries (TGA) is a defect where the usual right ventricle (RV)-
pulmonary artery (PA) and left ventricle (LV)-aorta relationships are reversed such that the 
RV is in continuity with the aorta while the LV is anatomically connected to the main PA 
(See Figure 1).  In general, there are 2 types of transposition that include this reversed 
ventricle-to-great artery relationship.  The first form, commonly referred to as “D-TGA”, 
involves an otherwise structurally normal heart with isolated transposition of the great 
vessels off the ventricles.  The second form, frequently called “L-TGA” or congenitally 
corrected transposition of the great arteries (CCTGA), involves transposed great arteries 
with additional atrial-to-ventricular transposition such that the right atrium empties into a 
morphologic LV while the left atrium empties into a morphologic RV. 
Surgical repair of both forms of TGA can involve an atrial switch procedure, either of the 
Mustard or Senning variety (See Figure 2).  In general, the atrial switch involves baffling 
blood from the superior and inferior vena cavae, within the atria, over to the left sided atrio-
ventricular (AV) valve and ventricle.  Pulmonary venous return is routed within the atria to 
empty into the right sided AV valve and ventricle(22). The current approach to the repair of 
D-TGA involves the arterial switch procedure where the aorta, coronary arteries and PA are 
removed from their respective ventricles and switched such that the aorta and coronaries 
are connected to the LV while the PA is anastomosed to the RV, thereby restoring normal 
ventricle-great artery continuity.  Atrial switches are still incorporated in combination with 
an arterial switch procedure in the so-called “double switch” procedure for anatomical 
repair of CCTGA.  
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Fig. 1. Transposition of the Great Arteries. 
Arrhythmias are frequently encountered in TGA patients who have undergone atrial switch 
procedures.  Sinus node dysfunction and atrial arrhythmias are often encountered in atrial 
switch patients and can be addressed with device implantation and/or catheter ablation(23).  
Ventricular arrhythmias and risk of sudden death have been addressed with ICD 
implantation in palliated TGA patients and have been associated with compromised 
systemic RV function(8). 
Atrial baffles present an element of complexity to lead implantation and extraction.   
The traditional approach of placing the atrial lead in the right atrial appendage or along 
the lateral right atrial wall is no longer possible.  Leads are generally placed through the 
SVC and atrial baffle over to the left atrial wall.  A location along the lateral atrial wall  
or in the left atrial appendage where reasonable sensing and pacing thresholds are 
achieved is selected for active lead fixation.  In similar fashion, the ventricular lead also 
courses through the baffle to the left sided AV valve and is fixated in the left sided 
ventricle. 
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Fig. 2. Atrial Switch Procedure.   
6.2 Tetralogy of Fallot 
Tetralogy of Fallot (TOF) is among the most common forms of cyanotic CHD encountered in 
pediatric patients.  In the current surgical era, complete repair is frequently undertaken in 
early infancy.  The defect consists of a primary abnormality in ventricular septal formation 
where the conal or outflow region of the ventricular septum is mal-aligned relative to the 
rest of the ventricular septum and anteriorly deviated into the space normally occupied by 
the right ventricular outflow tract.  This defect results in positioning of the aorta over the 
crest of the ventricular septum (overriding aorta) and the formation of a large ventricular 
septal defect (VSD) coupled with varying degrees of right ventricular outflow tract 
obstruction.  The RV undergoes compensatory hypertrophy completing the fourth 
component of TOF. 
Complete surgical repair consists of closure of the VSD with various materials along with 
a variety of interventions to augment the size of the right ventricular outflow tract.  This 
often involves a right ventriculotomy incision, resection of obstructive muscle bundles in 
the sub-pulmonary region, and trans-annular incisions and patch placement to increase 
the effective size of the pulmonary valve and main pulmonary artery segment.  While 
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ventricular level shunting and outflow tract obstruction are generally eliminated, patients 
are left with varying degrees of pulmonary insufficiency and impaired right ventricular 
hemodynamics.   
It is well recognized that repaired TOF patients are at risk for a variety of arrhythmic 
disturbances.  Atrial arrhythmias and sinus and AV node dysfunction are not infrequent.  
Ventricular arrhythmias related to macroreentry around incisions and patches and poor 
ventricular hemodynamics have been well described(24; 25). 
Lead extraction in repaired TOF patients can generally follow a similar approach to that in 
non-CHD patients.  Special attention should be given to previous device and surgical 
histories.  Many patients have undergone prior device implants with resultant vascular 
obstruction and others have undergone old approaches to device management with 
separate pacemaker and ICD systems implanted at the same time to address bradycardia 
and ventricular arrhythmias or sudden death risk.  Therefore, assessing vascular access 
becomes an important part of pre-procedural planning and great care must be taken to 
preserve transvenous access for the placement of new leads. 
6.3 Septal and AV Canal defects 
Patients with atrial and ventricular septal defects are usually repaired in early childhood 
with excellent outcomes.  Those with atrio-ventricular canal (AVC) defects comprise a 
spectrum of patients with variable long-term outcomes. 
Atrial septal defects (ASDs) come in several varieties, the most common being the 
secundum ASD where a septal hole exists that is enclosed circumferentially by atrial septal 
tissue.  This defect is easily repaired through patch closure or primary suture closure during 
surgery or through percutaneous means with a variety of deployable devices.  Primum type 
and sinus venosus type defects are more complicated forms of ASDs.  In sinus venous ASDs, 
the septal defect is located adjacent to the caval junctions with the atrium.  Anomalous 
pulmonary venous return is frequently associated with sinus venosus ASDs and surgical 
repair is needed and often involves baffling of the anomalous pulmonary venous blood flow 
back to the left atrium.  In primum type ASDs the defect is located inferiorly with the lower 
rim being bounded by the AV valve itself. 
Ventricular septal defects (VSDs) can involve any part of the ventricular septum and may 
come in the form of isolated holes in the septum, mal-alignment types as in TOF, or 
deficiencies in the septum related to abnormal formation of the AVC and incorporation of 
embryologic endocardial cushion tissue into the ventricular septum.  Defects in the 
membranous septum occur most frequently followed by muscular septal defects, both of 
which can usually be addressed through surgical patch closure.  AVC type VSDs involve 
deficiencies of the inlet ventricular septum and the superior border of the defect involves the 
AV valve.  Surgical closure is the dominant way of addressing VSDs however, percutaneous 
device-based methods can be employed to close certain types of muscular and membranous 
defects.  
AVC defects represent a group of septal defects that are associated with varying degrees of 
AV valve anomalies (See Figure 3).  Partial AVC defects consist of a primum type ASD with 
a cleft mitral valve.  Transitional AVC defects involve a primum type ASD, small or 
occluded VSD component, and abnormal left and right AV valves.  Complete AVC defects 
involve a large septal defect that spans both the atrial and ventricular septae and a single, 
common AV valve.  Surgical repair of such defects requires an extremely experienced 
surgeon who will be able to separate and re-create the AV valves and their supporting valve 
architecture while also closing the atrial and ventricular septal defects. 
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Fig. 3. AV Canal Defect. 
Arrhythmias and conduction system disease can arise in septal defect patients.  Prior cardiac 
surgery with an atriotomy incision and cannulation for cardiopulmonary bypass can result 
in sinus node dysfunction.  AV node dysfunction occurred in the earlier surgical era of VSD 
repairs as the conduction system fibers ran close to the defects and were often injured by 
patches and/or suture material.  Finally, in AVC type defects, the conduction system is 
inferiorly displaced, which also makes it prone to surgical trauma during repair attempts. 
Lead extraction in patients with standard forms of atrial or ventricular septal defects can be 
undertaken in a manner similar to non-CHD patients.  Repaired AVC defect patients can 
have unique anatomical features related to abnormal AV valve architecture and large 
ventricular septal patches.  Finally, pre-procedural imaging is critical to determine the 
presence or absence of residual septal shunting after surgical repair.  
6.4 Complex lesions (single ventricle hearts) 
Patients with severe forms of CHD involving single ventricle anatomy and physiology often 
require device-based therapies to treat sinus or AV node dysfunction and to treat and 
prevent lethal arrhythmias.  Single ventricle patients are palliated surgically with an 
eventual Fontan procedure where systemic venous blood is channeled directly to the 
pulmonary arterial tree (See Figure 4).  The single ventricle is isolated and used to pump 
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exclusively to the systemic circulation.  Fontan circulation involves the passive flow of 
systemic venous blood back to the lungs and is dependent on low vascular resistance within 
the pulmonary vasculature to promote venous return.  Multiple forms of the Fontan 
procedure have been devised with most patients in the current surgical era having either a 
lateral tunnel or extra-cardiac Fontan conduit placed to channel inferior vena caval blood 
flow to the lungs.  Superior caval blood is channeled to the lungs through a bidirectional 
Glenn anastomosis where the SVC is removed from the right atrium and connected in an 
end-to-side fashion to the right pulmonary artery.  Classic Fontan patients have a direct 
anastomosis of the right atrium to the pulmonary arteries.  Lateral tunnel and classic Fontan 
variants maintain an anatomical connection of the right atrial tissue with the systemic 
venous pathway. 
 
 
 
 
 
Fig. 4. The Fontan Circulation. 
Pacemaker and ICD therapy in Fontan patients is frequently applied through epicardial 
routes with few patients having transvenous atrial leads(26; 27). Therefore, device 
procedures will predominantly involve sternotomies with direct visualization to sever old 
leads and place new leads in a different location on the myocardium.  Transvenous atrial 
leads have occasionally been used in Fontan patients with isolated sinus node disease, 
particularly those with lateral tunnel or classic Fontan forms that permit venous to atrial 
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access for lead placement.  For patients with transvenous atrial leads, extraction can be 
performed but careful attention must be paid to risks of thromboembolic complications, 
risks of conduit tears, and bleeding.  In addition, placement of a new transvenous atrial lead 
may be challenging given a lack of reasonable endomyocardial targets with good sensing 
and pacing thresholds. 
7. General technique for lead extraction using the implant vein 
If the patient is pacemaker dependent, a temporary wire can be inserted from the groin or 
from the contra-lateral internal jugular or subclavian veins. Our center has found that 
placement of a temporary screw-in lead attached to an externally placed pacemaker pulse 
generator similar to what is implanted under the skin (tempo-permanent device) can be a 
useful tool in device dependent patients requiring extraction secondary to infection.  This 
approach allows patients to have stable back-up pacing while receiving intravenous 
antibiotics and remaining ambulatory on the floor, until they are cleared for permanent 
device re-implantation. 
To begin the extraction procedure, a small incision is made at the site of the previous pulse 
generator. Careful dissection is then undertaken in an effort to free up the leads and the 
device from the pocket.  Dissection is performed along the leads all the way down to the 
suture sleeves which are cut and removed.   
The dissected leads are then disconnected and tested.  Further dissection is then undertaken 
to the venous entry point.   Straight stylets are then inserted down the central lumen of each 
lead and an unsecured figure of eight stitch is done around the lead bodies to aid in 
hemostasis. If the lead is an active fixation lead, an attempt at retracting the fixation screw 
should be made.  We have frequently used a laser sheath for these complex extraction cases.  
In preparation for laser lead extraction, the dissected lead is cut with heavy scissors.  A 
sizing tool is inserted into the lead’s inner coil to help select the appropriate size of locking 
stylet. Next, the locking stylet is introduced and advanced to the distal part of the lead and 
expanded.  This stylet will be used to provide counter traction from the proximal part of the 
lead. Additionally, we tie a suture around the insulation and lead body and pass this suture 
through the laser sheath to provide further tension on the distal end of the lead. The laser 
sheath alone, or in combination with its outer Teflon sheath, is then inserted over the lead.  
Under fluoroscopic guidance, the sheath is carefully guided to the vein-lead interface.  
Staying coaxial to the lead, the laser sheath is advanced while counter-traction is kept on the 
lead with the locking stylet and the suture. Serial laser pulses are delivered during laser 
sheath advancement to heat the tissue and aid in the lysis of adhesions.  The outer sheath 
can also be advanced into the vein and carefully rotated to help disrupt adhesions. 
Additionally, significant scarring and calcifications can develop along the leads, especially 
as they course through baffles.(See Figure 5) Baffle stenosis can be present and involve 
existing pacemaker or defibrillator leads, thereby necessitating  baffle stenting and 
increasing the difficulty of extraction and re-implantation(28; 29).  Dense calcifications may 
limit the efficacy of laser applications and careful dissection through these regions may 
require blunt dissection with the laser sheath and/or outer sheath and necessitates that the 
operating physician exhibit great patience and care during this portion of the procedure.  
This advancement is continued until the lead body is free or the sheath is advanced all the 
way down to the myocardial tissue where the lead is fixated.  The same procedure is 
repeated for each lead to be removed.  
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Fig. 5. A PA chest X-ray demonstrating a ventricular lead coursing through the systemic 
baffle in a patient with D-Transposition of the great arteries.        
In the case of system infections, proper debridement of the pocket is also recommended, 
with complete removal of the capsule and debridement and removal of any scar tissue.  The 
pocket should be thoroughly irrigated with antibiotic solution.  In most patients the pocket 
can be loosely closed with interrupted sutures to allow drainage, unless there is gross pus 
present in the pocket.  In such cases, a Jackson-Pratt drain is placed in the pocket and 
delivered through a healthy portion of tissue below the incision. The pocket is then sutured 
with interrupted and evenly spaced non-absorbable sutures. Alternatively, if there is great 
concern over abscess formation and re-accumulation of pus, the wound can be left open and 
packed with antibiotic soaked gauze and allowed to heal by secondary intention.   
As many referrals for lead extraction are secondary to lead or device infection, the timeline 
for re-implantation in these patients becomes critical. As a general rule, the white blood cell 
count needs to be within normal limits or trending down and blood cultures need to be 
negative for at least 48 hours before considering re-implantation of a new system.  These 
guidelines are not standard though and will vary from center to center.  The duration of 
intravenous antibiotic treatment after re-implantation depends on the type of bacterium 
cultured, but generally lasts for 4-6 weeks.  Input from an infectious disease consultant 
regarding duration of antibiotic therapy and optimal timing for re-implantation is essential.  
8. Operator experience 
Analysis of lead extraction outcomes suggests that the frequency of complete procedural 
success improves dramatically after the first 10 procedures have been performed.  Lower 
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complication rates are associated with a prior experience of 30 procedures. The complication 
rate tends to keep improving after the first 30 procedures as the operator gains further 
experience. 
There is no specific data for the CHD population, but since the rate of complications appears 
to be similar, these general guidelines may also apply.  In general it is probably best that 
extractions in patients with CHD be done at centers with the necessary expertise and 
experience in both complex lead extractions and the management of adults with CHD.  
9. Complications 
The overall published complication rate for CHD patients undergoing lead extraction is 
consistently low (10; 19; 20).  The rate of major complications varies from 2.8 to 21% (10; 20).  
Major complications include induction of ventricular fibrillation and cardiac perforation 
with risk of tamponade.  Minor complications include pocket hematoma, superficial 
infection and excessive bleeding requiring transfusion. 
10. Conclusions 
Adults with CHD and implanted devices present unique challenges to the practitioner 
performing lead extractions.  While the general indications for lead extraction and the 
technical aspects of the procedure are similar in both CHD patients and those with 
structurally normal hearts, close attention needs to be paid to several features of CHD 
patients.  First the electrophysiologist must be aware of the specific CHD defect in each 
patient and the associated ramifications of prior surgical- and catheter-based interventions, 
complex device histories, and the importance of preserving the vascular space.  Overall, the 
use of laser sheaths to assist in lead extraction has greatly increased the safety and efficacy 
of this procedure in both the general population and adults with CHD(19; 30).  There 
remains a relative paucity of published data on device extraction in ACHD patients.  
However, the published reports suggest that device extraction is a safe and efficacious 
procedure in this patient population. 
Due to the highly variable anatomic substrates and additional complexities, all ACHD 
device extractions require meticulous pre-procedural planning.  Comprehensive review of 
the clinical and surgical history, inclusion of appropriate advanced imaging studies, 
incorporation of available tools as well as involvement of surgical and interventional 
services should all be routinely practiced to ensure successful outcomes while minimizing 
morbidity in a patient population that has had substantial exposure to medical and surgical 
interventions in the past. 
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